Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B. read more

EMPLOYEE PARTICIPANTS: 6

TOTAL RATINGS: 68

CEO: Matthew Kapusta

uniQure Executive Team

The uniQure Executive Team is rated an "A" and led by CEO Matthew Kapusta. uniQure employees rate their Executive Team in the Top 10% of similar size companies on Comparably with 201-500 Employees.

Out of their 3 competitors, Spark Therapeutics, bluebird bio, and Xencor, uniQure's score ranks in 1st place.

Last updated months ago.

Where This Score Ranks uniQure's Executive Team

TOP
10%
In the Top 10% of 1623 Similar Sized Companies on Comparably
1st
1st place versus 3 competitors rated on Comparably

Feb

Mar

A81 / 100

Jan

uniQure Key Executives

Name & Title

Bio

Who Ranks uniQure's Executive Team the Highest?

Not Enough Ratings To Show Who Ranks Executive Team the Highest

Anonymously rate my experience at uniQure

Who Ranks uniQure's Executive Team the Lowest?

Not Enough Ratings To Show Who Ranks Executive Team the Lowest

Anonymously rate my experience at uniQure

uniQure's Executive Team Trendline

uniQure93
Similar Size on Comparably

uniQure Executive Team At a Glance

The Executive Team Score of 81/100 is calculated by combining aggregate responses to the questions of “How would you rate your executive team?” and “Do you approve of the job your executive team is doing at your company?”

The last rating scoring uniQure's executive team was provided months ago and has remained stable at 81 over the last 90 days.